| # | Drug | Count |
|---|---|---|
| 0 | GABAPENTIN | 25 |
| 1 | METHOTREXATE SODIUM | 17 |
| 2 | FUROSEMIDE | 14 |
| 3 | METHOTREXATE | 14 |
| 4 | ASPIRIN | 13 |
| 5 | LEVOTHYROXINE SODIUM | 13 |
| 6 | PREDNISONE | 13 |
| 7 | ASPIRIN 325 MG | 12 |
| 8 | ASPIRIN 81 MG | 12 |
| 9 | OMEPRAZOLE MAGNESIUM | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POTASSIUM PHOSPHATE, MONOBASIC AND SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS | 1 | 0.0055 |
| 1 | BEPOTASTINE BESILATE | 1 | 0.0016 |
| 2 | DIFLUPREDNATE OPHTHALMIC | 1 | 0.0011 |
| 3 | ZAFIRLUKAST | 1 | 0.0011 |
| 4 | REVEFENACIN | 1 | 0.0011 |
| 5 | BEXAROTENE | 1 | 0.0008 |
| 6 | PSYLLIUM HUSK | 1 | 0.0007 |
| 7 | VANCOMYCIN HYDROCHLORIDE | 6 | 0.0007 |
| 8 | BUFFERED ASPIRIN | 1 | 0.0007 |
| 9 | PHENAZOPYRIDINE | 2 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 31 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 29 |
| 2 | Benzodiazepine [EPC] | 18 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 15 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 14 |
| 5 | Loop Diuretic [EPC] | 14 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 14 |
| 7 | beta-Adrenergic Blocker [EPC] | 12 |
| 8 | Opioid Agonist [EPC] | 10 |
| 9 | Histamine-2 Receptor Antagonist [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Antihypoglycemic Agent [EPC] | 2 | 0.0005 |
| 2 | Calcitonin [EPC] | 1 | 0.0003 |
| 3 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 4 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 5 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 6 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 7 | Thyroid Hormone Synthesis Inhibitor [EPC] | 2 | 0.0002 |
| 8 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 9 | Complement 5a Receptor Antagonist [EPC] | 1 | 0.0001 |